Literature DB >> 31252413

U-shaped relationship between iodine status and thyroid autoimmunity risk in adults.

Bin Wang1, Weiwei He2, Qian Li1, Xi Jia1, Qiuming Yao1, Ronghua Song3, Qiu Qin3, Jin-An Zhang3.   

Abstract

BACKGROUND: Iodine status has long been regarded as an environmental determinant for thyroid dysfunction, but its relationship with thyroid autoimmunity (TAI) is still controversial. Our study aimed to elucidate the relationship between iodine status and TAI through both a population-based study and a dose-response meta-analysis of eligible epidemiological studies.
METHODS: A population-based, cross-sectional study was firstly carried out, which enrolled a total of 2808 Chinese adults. Odds ratio (OR) with 95% confidence interval (95% CI) was calculated through logistic regression analysis. A dose-response meta-analysis of eligible epidemiological studies was also carried out.
RESULTS: The cross-sectional study showed an U-shaped relationship between iodine intake and TAI in adults. Compared with those with more than adequate iodine status, individuals with iodine deficiency, adequate iodine status and iodine excess all had higher risk of TAI, and the adjusted ORs were 1.50 (95% CI 1.03-2.17, P = 0.032), 1.50 (95% CI 1.09-2.07, P = 0.013) and 1.68 (95% CI 1.11-2.53, P = 0.014), respectively. The dose-response meta-analysis included 22 epidemiological studies with a total of 69,987 participants and further validated the U-shaped relationship between iodine intake and TAI in adults, which proved the significantly increased risk of TAI among individuals with either iodine deficiency or iodine excess. Stratified analysis of studies with low risk of confounding bias also identified similar findings.
CONCLUSION: The study suggests an U-shaped relationship between iodine intake and TAI in adults, and both iodine deficiency and iodine excess are risk factors of TAI in adults. The underlying mechanisms need to be elucidated in future studies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31252413     DOI: 10.1530/EJE-19-0212

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

1.  Predictors of autoimmune thyroid disease.

Authors:  Carol Cardona Attard; W C Candy Sze; Sandro Vella
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-06-15

2.  Inverse Association Between Iodine Status and Prevalence of Metabolic Syndrome: A Cross-Sectional Population-Based Study in a Chinese Moderate Iodine Intake Area.

Authors:  Jing Zhao; Yinbiao Su; Jin-An Zhang; Ming Fang; Xuerong Liu; Xi Jia; Xinming Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-08-20       Impact factor: 3.168

3.  The risk of perchlorate and iodine on the incidence of thyroid tumors and nodular goiter: a case-control study in southeastern China.

Authors:  Huirong Wang; Yousheng Jiang; Jiayi Song; Huiwen Liang; Yuan Liu; Jiewu Huang; Pengliang Yin; Dongting Wu; Hang Zhang; Xinjie Liu; Dongxian Zhou; Wei Wei; Lin Lei; Ji Peng; Jianqing Zhang
Journal:  Environ Health       Date:  2022-01-04       Impact factor: 5.984

4.  Pregnant Dutch Women Have Inadequate Iodine Status and Selenium Intake.

Authors:  K Clara Mayunga; Melany Lim-A-Po; Janniek Lubberts; Eline Stoutjesdijk; Daan J Touw; Frits A J Muskiet; D A Janneke Dijck-Brouwer
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

Review 5.  Thyroidal and Extrathyroidal Requirements for Iodine and Selenium: A Combined Evolutionary and (Patho)Physiological Approach.

Authors:  D A Janneke Dijck-Brouwer; Frits A J Muskiet; Richard H Verheesen; Gertjan Schaafsma; Anne Schaafsma; Jan M W Geurts
Journal:  Nutrients       Date:  2022-09-20       Impact factor: 6.706

6.  Urinary Iodine Concentration in a Cohort of Adult Outpatients with Thyroid Diseases in Liguria 14 Years after the Law on Salt Iodization.

Authors:  Lucia Conte; Martina Comina; Eleonora Monti; Marilena Sidoti; Ornella Vannozzi; Lucia Di Ciolo; Flavia Lillo; Massimo Giusti
Journal:  Nutrients       Date:  2019-12-19       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.